Table 2. Diagnostic performance, design, and quality of included studies.
Author (Ref) | Cases | Controls | TP | FP | FN | TN | Design | Blinded? | QUADAS |
---|---|---|---|---|---|---|---|---|---|
Bassarova AV [17] | 32 | 250 | 32 | 128 | 0 | 122 | NA | NA | 8 |
Saad RS [18] | 20 | 20 | 17 | 0 | 3 | 20 | R | Yes | 8 |
Bhalla R [19] | 10 | 10 | 10 | 0 | 0 | 10 | R | NA | 9 |
Hyun TS [20] | 11 | 21 | 9 | 0 | 2 | 21 | R | Yes | 10 |
Ordóñez NG [21] | 40 | 123 | 29 | 8 | 11 | 115 | NA | NA | 11 |
Chu AY [22] | 53 | 125 | 51 | 27 | 2 | 98 | R | NA | 12 |
Müller AM [23] | 36 | 76 | 22 | 27 | 14 | 49 | NA | NA | 10 |
Ordóñez NG [24] | 40 | 45 | 37 | 6 | 3 | 39 | NA | NA | 11 |
Comin CE [25] | 15 | 40 | 14 | 8 | 1 | 32 | R | NA | 9 |
Mimura T [26] | 66 | 66 | 56 | 3 | 10 | 63 | R | NA | 11 |
Padgett DM [27] | 44 | 101 | 38 | 4 | 6 | 97 | R | NA | 12 |
Amatya VJ [28] | 80 | 80 | 74 | 13 | 6 | 67 | R | NA | 12 |
Deniz H [29] | 37 | 36 | 19 | 0 | 18 | 36 | R | NA | 11 |
Takeshima Y [30] | 45 | 27 | 39 | 7 | 6 | 20 | R | NA | 10 |
Hu YC [31] | 36 | 31 | 25 | 2 | 11 | 29 | R | NA | 10 |
Kao SC [32] | 80 | 21 | 80 | 0 | 0 | 21 | R | NA | 9 |
Comin CE [33] | 75 | 172 | 73 | 25 | 2 | 147 | R | NA | 10 |
Guo Z [8] | 43 | 35 | 38 | 24 | 5 | 11 | R | NA | 12 |
Kawai T [34] | 22 | 11 | 17 | 3 | 5 | 8 | P | NA | 11 |
Carbone M [5] | 10 | 45 | 8 | 10 | 2 | 35 | R | NA | 10 |
Amatya VJ [35] | 31 | 29 | 22 | 9 | 9 | 20 | R | Yes | 12 |
Kushitani K [36] | 36 | 38 | 35 | 23 | 1 | 15 | R | NA | 11 |
NA: Not available; P: Prospective; R: Retrospective; FN: False negative; FP: False positive; TN: True negative;
TP: True positive; QUADAS: Quality assessment for diagnostic accuracy studies.